Watchlist for September 25, 2007

Well things are considerably more interesting today. News from Target (TGT) & Lowes (LOW) is helping to push the S&P back into last Tuesday's post-Fed range. It's important for the bulls to defend those euphoric gains. I think the obvious first support level to watch is 1,500. Let the games begin...

On Today's Calendar:

10:00 -- Consumer Confidence
10:00 -- Existing Home Sales

More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic

Potential swing trades:

See one of the recent 'Chart Reading' posts for some potential swing candidates.

Potential day trades:

(From Briefing.com)

Gapping Down

On weak earnings/guidance: MSSR -12.1%, LEN -6.7% (other homebuilders gapping down in sympathy KBH -3.9%, BZH -4.5%, PHM -4%, HOV -3.1%; group also initiated with a pessimistic view at UBS), LOW -5.1% (HD gapping down 1.9% in sympathy), TGT -4% (lowers Sept comp guidance)... Other news: CEA -12.1% and ZNH -5.7% (Cathay Pacific drops Eastern China bid, reports Bloomberg), MXIM -4.7% (replaced in the S&P 500), DMGI -4.2% (CFO and interim CEO to resign).

Gapping Up

Gapping up on strong earnings/guidance: KRSL +13.4%... S&P announces changes to U.S. Indices; the following stocks are gapping up after being added to the S&P 500: EXPE +6.1%, TSO +3.4%, ICE +3.3%... Chinese telecom stocks are up with reports that China will soon issue 3G licenses, and a separate report that the govt will overhaul the telecommunication industry: CHA +6.3%, CHU +2.1%, CHL +1.6%... Other news: SCON +24.2% (signs term sheet for joint venture with Hunchun BaoLi Communication), FMCN +9.7% (files delayed Form 20-F; co completed previously disclosed investigation), AKNS +9.6% (co partners with STP to manufacture new solar panel; see yesterday's New High Profile comment for background on AKNS), VCLK +6.4% (Jon Najarian on CNBC highlights recent call buying and takeover rumors in VCLK), CDS +5.8% (announces that its subsidiary Jinwei Magnesium has commenced the production of magnesium at its new manufacturing facilities; see yesterday's profile for more information on CDS), TGB +3.1% (announces positive feasibility study for prosperity project), ARNA +2.4% (announces 'Positive' Phase 2 clinical trial results of APD125 for the treatment of insomnia).